Exploring Knowledge Management in the Pharmaceutical Industry
Nuala F. Calnan, PhD
An investment in knowledge pays the best interest
-- Benjamin Franklin
Since 2008 and the publication of ICH Q10, the importance of the role of knowledge management has been clearly positioned as one of two key enablers necessary for the successful implementation of an effective pharmaceutical quality system. In the intervening years, many organizations have engaged in earnest on their quest to manage the knowledge locked within.
Last November, at ISPE’s Annual Meeting in Washington, there was much buzz among the delegates about the article in Pharmaceutical Engineering on a case study from Merck on their Knowledge Management (KM) evolution. In a meeting I had with Gloria Hall, Editor and Director of Publications at ISPE, we discussed the fact that while the regulators had set out their high- level expectations for knowledge management, the industry was still grappling with how to deliver real programs that address the many complexities of capturing, converting and communicating the existing and emerging knowledge within their organizations. The seed was sown for us to start work on a dedicated Pharmaceutical Engineering E-supplement on knowledge management in the pharmaceutical industry.
This supplement will be available for download in May. As a researcher in the field of ICH Q8-Q11 implementation and longtime ISPE volunteer, I was happy to take on the task of ‘curating’ the supplement and set about seeking diverse inputs from regulators, industry, service providers and academia. What I found was a real appetite for sharing experience, current practice and practical resources. ISPE now brings to you ten thought provoking contributions on the subject of managing knowledge including:
Three KM approaches from Merck, Takeda and Roche
Two contributions from the international regulatory community (EU and Japan)
Current thinking from leading service providers on the Long Tail of Knowledge (APQC), The Role of Taxonomies (SmartLogic) and Documenting Process Knowledge (CAI)
Academic input on the role of tacit knowledge and the evolution of knowledge within the new regulatory paradigm
A guide to the available ISPE PQLI knowledge resources
Much has been written in recent years about the knowledge continuum (data, information, understanding, knowledge and wisdom). Ultimately, in our industry, wisdom lies in our ability to recognize the role that knowledge plays in enhancing our patient-focused decision making capabilities in every batch, every day. ISPE hopes that this supplement will invigorate an industry dialog on knowledge management. We welcome your feedback and suggestions.
Pharmaceutical Engineering is introducing a new part of the Pharmaceutical Engineering Online site: Online Exclusives. This content will be published only to the ISPE web site—it will not be published in print. Read on for FAQs about this new feature,...
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from February 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last...
As we continue to monitor the COVID-19 pandemic, our thoughts are with our Members and those impacted. We recognize that the ever-changing impact of this novel virus is disruptive to so many aspects of our personal and professional lives. We are not...